Allogeneic transplantation for hepatosplenic αβ T-cell lymphoma [3]

Bone Marrow Transplantation

Volumn 35, Issue 9, 2005, Pages 931-934

  Mansour, M R ^a   Dogan, A ^b   Morris, E C ^a   Khwaja, A ^a   Linch, D C ^a   Mackinnon, S ^a   Peggs, K S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR 7; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; MELPHALAN; METHYLPREDNISOLONE; PANTOPRAZOLE; THIOTEPA; THYMOCYTE ANTIBODY; VINCRISTINE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; FEMALE; GASTROINTESTINAL HEMORRHAGE; GRAFT VERSUS HOST REACTION; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; LETTER; PRIORITY JOURNAL; PROGNOSIS; T CELL LYMPHOMA; WHOLE BODY RADIATION;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHOMA, T-CELL; SPLENIC NEOPLASMS; TRANSPLANTATION, HOMOLOGOUS;

EID: 18744402793     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704897     Document Type: Letter

References (13)

1. Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000; 14: 991-997.
2. Belhadj K, Reyes F, Farcet JP et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003; 102: 4261-4269.
3. Macon WR, Levy NB, Kurtin PJ et al. Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. Am J Surg Pathol 2001; 25: 285-296.
4. Kumar S, Lawlor C, Jaffe ES. Hepatosplenic T-cell lymphoma of alpha beta lineage. Am J Surg Pathol 2001; 25: 970-971.
5. Dong J, Chong YY, Meyerson H. Hepatosplenic alpha beta T-cell lymphoma - a report of an S100-positive case. Arch Pathol Lab Med 2003; 127: e119-e122.
6. Chanan-Khan A, Islam T, Alam A et al. Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma. Leuk Lymphoma 2004; 45: 1673-1675.
7. Lai R, Larratt L, Etches W et al. Hepatosplenic T-cell lymphoma of alpha beta lineage in a 16-year old boy presenting with haemolytic anemia and thrombocytopenia. Am J Surg Pathol 2000; 24: 459-463.
8. Jonveaux P, Daniel MT, Martel V et al. Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma/delta lymphoma. Leukemia 1996; 10: 1453-1455.
9. Cooke CB, Krenacs L, Stetler-Stevenson M et al. Hepatosplenic T cell lymphoma: a distinct clinicopathological entity of cytotoxic gamma delta T-cell origin. Blood 1996; 88: 4265-4274.
10. Gassas A, Kirby M, Weitzman S et al. Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation. Am J Hematol 2004; 75: 113-114.
11. Ooi J, Iseki T, Adachi D et al. Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma. Haematologica 2001; 86: E25.
12. Aldinucci D, Poletto D, Zagonel V et al. In vitro and in vivo effects of 2′-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta + T-cell malignancies. Br J Haematol 2000; 110: 188-196.
13. Przybylski G, Wu H, Macon W et al. Hepatosplenic and subcutaneous panniculitis-like γ/δ T cell lymphomas are derived from different Vδ subsets of γ/δ T lymphocytes. J Mol Diag 2000; 2: 11-19.